Δ vs 2025-Q4 · % of shares outstanding not shown: this line files 20-F annual reports only — a foreign private issuer whose US listing trades as ADSs (depositary receipts), while its cover-page share count is in ORDINARY shares. The depositary ratio is not in our data. The count we hold for this line is 701,680,440 shares (as of 2025-12-31, source dei). Dividing one by the other is wrong by the whole ratio (a 5:1 ADR reads one fifth of the true percentage), so the percentage is withheld rather than served wrong. Holder share counts are shown as filed. · 13F holders shown for the US-listed sibling PHAR — institutions file against the US line; figures are that listing's shares, not the requested one's.ⓘ

No reported quarters on file for PHARM.AS.